Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia | Zendy

Rickerts V. | Zendy; Atta J. | Zendy; Herrmann S. | Zendy; Jacobi V. | Zendy; Lambrecht E. | Zendy; Bialek R. | Zendy; JustNübling G. | Zendy

Premium

Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia

Author(s) -

Rickerts V.,

Atta J.,

Herrmann S.,

Jacobi V.,

Lambrecht E.,

Bialek R.,

JustNübling G.

Publication year - 2006

Publication title -

mycoses

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.13

H-Index - 69

eISSN - 1439-0507

pISSN - 0933-7407

DOI - 10.1111/j.1439-0507.2006.01299.x

Subject(s) - posaconazole , mucormycosis , amphotericin b , medicine , antifungal , zygomycosis , myeloid leukaemia , surgery , dermatology

The combination of resection of infected tissue and antifungal therapy is the treatment of choice in mucormycosis. In disseminated mucormycosis, where surgery is impossible, the mortality is almost 90%. We report the first case of disseminated mucormycosis that was cured with a combination therapy of liposomal amphotericin B and posaconazole without surgical intervention.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research